Clinical differences among nonsteroidal antiinflammatory drugs: implications for therapeutic substitution in ambulatory patients.
The practice of therapeutic substitution, i.e., replacing one drug with another chemically different drug from the same therapeutic class, represents an important therapeutic modification with potential clinical significance far beyond that of generic substitution. Adverse consequences following therapeutic substitution of nonsteroidal antiinflammatory drugs (NSAID) is of special concern because of substantial differences among these agents in pharmacokinetic, pharmacological, and clinical properties. Therapeutic substitution of NSAID for ambulatory patients may result in compromised clinical outcome because (1) patient response is unpredictable and selection of the optimal agent must be tailored for each patient; (2) substantial differences exist in adverse reaction profiles; (3) drug interaction studies are lacking; and (4) selection of an agent must be individualized to ensure compliance with the dosing regimen. Cost savings achieved through therapeutic substitution of NSAID may be lost by additional overall treatment costs due to adverse reactions or suboptimal therapy. The occurrence of adverse or suboptimal effects in ambulatory patients is more likely if NSAID are substituted without full knowledge of the patient's medical history and clinical status. Communication between the pharmacy and prescribing physician regarding a patient's specific needs is essential for rational substitution among NSAID.
Levy
R A
RA
Scientific Affairs, National Pharmaceutical Council, Reston, VA 22091.
Smith
D L
DL
D000553:Ambulatory Care; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000145:classification / Q000493:pharmacokinetics / Q000494:pharmacology; D004347:Drug Interactions; D011307:Drug Prescriptions / Q000191:economics; D006801:Humans; D008329:Managed Care Programs / Q000191:economics; D010349:Patient Compliance; D011306:Prescription Fees; D013810:Therapeutic Equivalency; D014481:United States
D000894:Anti-Inflammatory Agents, Non-Steroidal